skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Wiley Online Library remover nível superior: Recursos Online remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Etoposide‐Entrapped Progesterone‐Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide‐Resistant Colorectal Cancer Cells
Etoposide‐Entrapped Progesterone‐Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide‐Resistant Colorectal Cancer Cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Etoposide‐Entrapped Progesterone‐Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide‐Resistant Colorectal Cancer Cells

Tanveer Ahmed, Mohammed ; Sarkar, Sampa ; Shukla, Ravi ; Banerjee, Rajkumar

Chembiochem : a European journal of chemical biology, 2023-06, Vol.24 (12), p.e202200650-n/a [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia
M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia
Material Type:
Artigo 		Adicionar ao Meu Espaço

M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia

Singh, Kam ; Gillett, Sarah ; Ireson, Jane ; Hills, Anne ; Tidy, John A. ; Coleman, Robert E. ; Hancock, Barry W. ; Winter, Matthew C.

International journal of cancer, 2021-05, Vol.148 (9), p.2335-2344 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
3
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer

Gao, Ya ; Shi, Shuzhen ; Liu, Ming ; Wu, Fanqi ; Zhang, Junhua ; Song, Fujian ; Tian, JinHui

Cochrane database of systematic reviews, 2021-10, Vol.2021 (10) [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
4
Requirement for etoposide in the initial treatment of Epstein‐Barr virus–associated haemophagocytic lymphohistiocytosis
Requirement for etoposide in the initial treatment of Epstein‐Barr virus–associated haemophagocytic lymphohistiocytosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Requirement for etoposide in the initial treatment of Epstein‐Barr virus–associated haemophagocytic lymphohistiocytosis

Song, Yue ; Wang, Yini ; Wang, Zhao

British journal of haematology, 2019-09, Vol.186 (5), p.717-723 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
First‐Line Durvalumab in Addition to Etoposide and Platinum for Extensive‐Stage Small Cell Lung Cancer: A U.S.‐Based Cost‐Effectiveness Analysis
First‐Line Durvalumab in Addition to Etoposide and Platinum for Extensive‐Stage Small Cell Lung Cancer: A U.S.‐Based Cost‐Effectiveness Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

First‐Line Durvalumab in Addition to Etoposide and Platinum for Extensive‐Stage Small Cell Lung Cancer: A U.S.‐Based Cost‐Effectiveness Analysis

Lin, Shen ; Luo, Shaohong ; Gu, Dian ; Li, Meiyue ; Rao, Xin ; Wang, Changlian ; Huang, Pinfang ; Xu, Xiongwei ; Weng, Xiuhua

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.e2013-e2020 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
6
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission

Zhao, Xiaoyan ; Xu, Ziwei ; Li, Ziying ; Zhou, Xi ; Hu, Yu ; Wang, Huafang

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
7
Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO2@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer
Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO2@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO2@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer

Zhu, Yanjing ; Zhu, Rongrong ; Wang, Mei ; Wu, Bin ; He, Xiaolie ; Qian, Yechang ; Wang, Shilong

Advanced science, 2016-11, Vol.3 (11), p.1600229-n/a [Periódico revisado por pares]

Hoboken: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
8
Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay
Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay
Material Type:
Artigo 		Adicionar ao Meu Espaço

Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay

Beig, Avital ; Miller, Jonathan M. ; Lindley, David ; Carr, Robert A. ; Zocharski, Philip ; Agbaria, Riad ; Dahan, Arik

Journal of pharmaceutical sciences, 2015-09, Vol.104 (9), p.2941-2947 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment
Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment

Ohuchi, Kentaro ; Fujimura, Taku ; Kambayashi, Yumi ; Amagai, Ryo ; Lyu, Chunbing ; Tanita, Kayo ; Sato, Yota ; Aiba, Setsuya

Dermatologic therapy, 2020-07, Vol.33 (4), p.e13487-n/a [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
10
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas

Sengar, Manju ; Jain, Hasmukh ; Shet, Tanuja ; Sridhar, Epari ; Gota, Vikram ; Rangarajan, Venkatesh ; Laskar, Siddhartha S ; Alahari, Aruna ; Thorat, Jayashree ; Agarwal, Archi ; Sharma, Neha ; Gupta, Himanshi ; Kannan, Sadhana ; Kumar, Shikhar ; Nayak, Lingaraj ; Menon, Hari ; Gujral, Sumeet ; Bagal, Bhausaheb

British journal of haematology, 2023-02, Vol.200 (4), p.429-439 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (22.698)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (23.268)
  2. Reports  (181)
  3. Anais de Congresso  (12)
  4. magazinearticle  (6)
  5. Mais opções open sub menu

Assunto 

  1. Science & Technology  (19.548)
  2. Life Sciences & Biomedicine  (19.106)
  3. Humans  (16.256)
  4. Male  (8.043)
  5. Female  (8.029)
  6. Oncology  (7.926)
  7. Biological And Medical Sciences  (5.458)
  8. Medical Sciences  (5.271)
  9. Chemotherapy  (5.199)
  10. Hematology  (5.161)
  11. Adult  (5.062)
  12. Middle Aged  (4.757)
  13. Aged  (3.533)
  14. Tumors  (3.231)
  15. Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use  (3.148)
  16. Adolescent  (3.016)
  17. Pediatrics  (2.873)
  18. Child  (2.775)
  19. Animals  (2.689)
  20. Prognosis  (2.547)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1976  (24)
  2. 1976Até1987  (185)
  3. 1988Até1999  (2.471)
  4. 2000Até2012  (9.917)
  5. Após 2012  (10.871)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (23.457)
  2. Japonês  (3.826)
  3. Alemão  (63)
  4. Norueguês  (6)
  5. Francês  (5)
  6. Russo  (2)
  7. Coreano  (2)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.